Predictors of adherence to triptans: Factors of sustained vs lapsed users

Headache

Volumn 49, Issue 3, 2009, Pages 386-394

  Cady, Roger K ^a,b   Maizels, Morris ^c   Reeves, Dennis L ^b   Levinson, Daniel M ^d   Evans, Judith K ^e  

^a HEADACHE CARE CENTER   (United States)

^b Clinvest   (United States)

^c KAISER PERMANENTE   (United States)

^d National Cognitive Recovery Foundation   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

HIT 6; MIDAS; Migraine; Pain free; Questionnaire; Triptans

Indexed keywords

NARCOTIC ANALGESIC AGENT; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH MAINTENANCE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; STRUCTURED QUESTIONNAIRE; TREATMENT RESPONSE;

ADULT; DATABASES, BIBLIOGRAPHIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MIGRAINE DISORDERS; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PATIENT SATISFACTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; TRYPTAMINES;

EID: 61349095413     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01343.x     Document Type: Article

References (28)

1. Cady RK, Farmer KU, Schreiber CP. Understanding The patient with migraine: The evolution from episodic headache to chronic neurological disease. A proposed classification of patients with headache. Headache. 2004 44 : 426 435.
2. Bigal ME, Lipton RB. Concepts and mechanisms of migraine chronification. Headache. 2008 48 : 7 15.
3. Scher AI, Midgette LY, Lipton RB. Risk factors for headache chronification. Headache. 2008 48 : 16 25.
4. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992 267 : 64 69.
5. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: Results from the American Migraine Study. Headache. 1998 38 : 87 96.
6. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: Data from the American Migraine Study II. Headache. 2001 41 : 646 657.
7. Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008 48 : 553 563.
8. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs J Jr. Treatment of acute migraine with subcutaneous sumatriptan. JAMA. 1991 265 : 2831 2835.
9. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991 325 : 316 321.
10. Cady R. Looking forward: The expanding utility of sumatriptan and naratriptan. Cephalalgia. 2001 21 (Suppl. 1 35 38.
11. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 22 : 633 658.
12. Bell CF, Foley KA, Barlas S, Solomon G, Hu H. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: A multicenter, prospective, open-label two-attack, crossover study. Clin Ther. 2006 28 : 872 880.
13. Cady RK, Lipton RB, Hall C, et al. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study. Headache. 2000 40 : 792 797.
14. Diener HC. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice. Headache. 2005 45 : 624 631.
15. Cady R, Martin V, Mauskop A, et al. Symptoms of cutaneous sensitivity pre-treatment and post-treatment: Results from the rizatriptan TAME studies. Cephalalgia. 2007 27 : 1055 1060.
16. Brandes JL, Kudrow D, Cady R, Tiseo PJ, Sun W, Sikes CR. Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing. Cephalalgia. 2005 25 : 735 742.
17. Carpay J, Schoenen J, Ahmad F, Kinrade F, Boswell D. Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: Results of a multicenter, randomized, placebo-controlled study. Clin Ther. 2004 26 : 214 223.
18. Lipton RB, Cady RK, Stewart WF, Wilks K, Hall C. Diagnostic lessons from the spectrum study. Neurology. 2002 58 (9 Suppl. 6 S27 S31.
19. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache. 2002 42 (Suppl. 1 3 9.
20. Farmer K, Cady R, Bleiberg J, et al. Sumatriptan nasal spray and cognitive function during migraine: Results of an open-label study. Headache. 2001 41 : 377 384.
21. Jakubowski M, Levy D, Goor-Areyeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005 45 : 850 861.
22. Diamond S, Bigal ME, Silberstein S. Lipton RB. Patterns of diagnosis and acute preventive treatment for migraine in the United States: Results from the American Migraine Prevalence and Prevention Study. Headache. 2007 47 : 355 363.
23. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, on behalf of the AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007 68 : 343 349.
24. Stovner LJ, Scher AI. Epidemiology of headache. In : Olesen J, Goadsby P, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches. Philadelphia, PA: Lippincott, Williams & Wilkins 2005 : 17 26.
25. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: A randomized controlled trial. JAMA. 2004 291 : 965 973.
26. Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: Results from the American Migraine Study II. Headache. 2001 41 : 638 645.
27. International Headache Society Clinical Trials Subcommittee Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia. 2000 20 : 765 786.
28. Foley KA, Cady RK, Martin V, et al. Treating early vs treating mild: Timing of migraine prescription medications among patients with diagnosed migraine. Headache. 2005 45 : 538 545.